SCHEMBL9524436

SCHEMBL9524436

CCC(C)CCCCCCOc1cnc(-c2ccc(OC[C@H]3COC(C)(C)O3)cc2)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
KDM4E B2RXH2 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MAPT P10636 1/20 0.36
CCNK O75909 1/20 0.34
CDK12 Q9NYV4 1/20 0.34
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPK14 Q16539 8/20 0.33
RARB P10826 1/20 0.32
ACACB O00763 1/20 0.32
ALDH1A1 P00352 2/20 0.31
HPGD P15428 2/20 0.31
HTT P42858 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CYP19A1 P11511 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9524444 1.00 NPC1 (0.37) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL9524670 0.88 NPC1 (0.46) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL9524673 0.88 NPC1 (0.46) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL9524446 0.81 NPC1 (0.31) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL9239218 0.79 NPC1 (0.57) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL9239947 0.78 NPC1 (0.56) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL10469343 0.78 NPC1 (0.56) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL10467948 0.78 NPC1 (0.56) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL10467929 0.78 NPC1 (0.56) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL10468279 0.78 NPC1 (0.56) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0351746-B1 Optically active 1,3-dioxolane derivatives containing a mesogene group in position 4, method for their preparation and their use as doping agents in liquid-crystal mixtures HOECHST AG (DE) 1993-12-29 EP disclosed
EP-0351746-A1 Optically active 1,3-dioxolane derivatives containing a mesogene group in position 4, method for their preparation and their use as doping agents in liquid-crystal mixtures HOECHST AKTIENGESELLSCHAFT (DE) 1990-01-24 EP disclosed